论文部分内容阅读
1969年 Kountz 首先在临床上使用了甲基强的松龙琥珀酸钠(M-PSL)冲击疗法。本文报告在自身免疫性溶血性贫血(AIHA)、血小板减少性紫癜(ITP),患者中使用本疗法的3例观察。M-PSL 剂量为20mg/kg/d(最高1.Og/d),用所附之缓冲液溶解后混于5%葡萄糖100ml中,在1~2小时内静脉滴注,连用3天为1疗程,必要时每隔1~2周重复1次。例1,14岁,女。入院时明显贫血和黄疸,末梢血红细胞110万、血红蛋白4.0g,出现球形细胞,血小板2.1万,网织红细胞30.1%,红细胞呈高度自然
In 1969 Kountz first clinically used methylprednisolone sodium succinate (M-PSL) shock therapy. This article reports the use of this therapy in 3 patients with autoimmune hemolytic anemia (AIHA) and thrombocytopenic purpura (ITP). M-PSL dose of 20mg / kg / d (up to 1.Og / d), with the attached buffer dissolved in 100ml of 5% glucose in 1 to 2 hours intravenous infusion, once every 3 days for 1 Course of treatment, if necessary, repeat every 1 to 2 weeks. Example 1, 14 years old, female. Obvious anemia and jaundice on admission, 1.1 million peripheral red blood cells, hemoglobin 4.0g, spherical cells, platelets 21,000, reticulocyte 30.1%, red blood cells were highly natural